Results · Apr-Jun 2026 · filed 9 Sep 2026
Hemo Organic Q1 FY27 results
Sales fell 100% to ₹0 crore from ₹0 crore in Apr-Jun 2025.
The net loss narrowed to ₹0.07 crore from ₹0.09 crore.
Against Jan-Mar 2026: sales −100%, loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.0 | 0.0 | −100% |
| Operating profit (EBITDA) | -0.1 | -0.1 | n/m |
| Operating margin | - | −6021.1% | - |
| Net profit | -0.1 | -0.1 | loss narrows |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 8 quarters
Filings that week
- 9 Sep 2026Announcement under Regulation 30 (LODR)-Cessation
- 9 Sep 2026Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- 9 Sep 2026Submission Of Voting Results Of Annual General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regul
- 9 Sep 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 9 Sep 2026Announcement under Regulation 30 (LODR)-Change in Directorate
- 9 Sep 2026Board Meeting Outcome for Outcome Of The Board Meeting Held Toady I.E., Wednesday, 9Th September, 2026.
- 8 Sep 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.